Back to mobile site

Alnylam Pharma (ALNY) Granted Accelerated Assessment of Patisiran by EMA

November 13, 2017 7:33 AM EST Send to a Friend
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login